Correlation Between Check Point and Vertex Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Check Point and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Check Point and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Check Point Software and Vertex Pharmaceuticals Incorporated, you can compare the effects of market volatilities on Check Point and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Check Point with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Check Point and Vertex Pharmaceuticals.

Diversification Opportunities for Check Point and Vertex Pharmaceuticals

-0.02

Correlation Coefficient

Check Point  Vertex Pharmaceuticals

Good diversification

The 3 months correlation between Check and Vertex is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Check Point Software and Vertex Pharmaceuticals Incorpo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Check Point is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Check Point Software are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Check Point i.e., Check Point and Vertex Pharmaceuticals go up and down completely randomly.

Pair Corralation between Check Point and Vertex Pharmaceuticals

Assuming the 90 days trading horizon Check Point Software is expected to generate 0.88 times more return on investment than Vertex Pharmaceuticals. However, Check Point Software is 1.13 times less risky than Vertex Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Vertex Pharmaceuticals Incorporated is currently generating about 0.06 per unit of risk. If you would invest  33,766  in Check Point Software on October 6, 2024 and sell it today you would earn a total of  24,988  from holding Check Point Software or generate 74.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.67%
Values	Daily Returns

Check Point Software  vs.  Vertex Pharmaceuticals Incorpo

Check Point Software

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Check Point Software are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical indicators, Check Point sustained solid returns over the last few months and may actually be approaching a breakup point.

Vertex Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceuticals Incorporated are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Vertex Pharmaceuticals is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Check Point and Vertex Pharmaceuticals

The main advantage of trading using opposite Check Point and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Check Point position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.

The idea behind Check Point Software and Vertex Pharmaceuticals Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.